Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP181661.RAyju-kl1KkTd36Ulc9OLK2isBjWfu7Mv9zR_cQw2Vv8k130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP181661.RAyju-kl1KkTd36Ulc9OLK2isBjWfu7Mv9zR_cQw2Vv8k130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP181661.RAyju-kl1KkTd36Ulc9OLK2isBjWfu7Mv9zR_cQw2Vv8k130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP181661.RAyju-kl1KkTd36Ulc9OLK2isBjWfu7Mv9zR_cQw2Vv8k130_provenance.
- NP181661.RAyju-kl1KkTd36Ulc9OLK2isBjWfu7Mv9zR_cQw2Vv8k130_assertion description "[However, we did not find any association between TSNAX and BP or the fluvoxamine therapeutic response in MDD in the allele/genotype analysis or haplotype analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181661.RAyju-kl1KkTd36Ulc9OLK2isBjWfu7Mv9zR_cQw2Vv8k130_provenance.
- NP181661.RAyju-kl1KkTd36Ulc9OLK2isBjWfu7Mv9zR_cQw2Vv8k130_assertion evidence source_evidence_literature NP181661.RAyju-kl1KkTd36Ulc9OLK2isBjWfu7Mv9zR_cQw2Vv8k130_provenance.
- NP181661.RAyju-kl1KkTd36Ulc9OLK2isBjWfu7Mv9zR_cQw2Vv8k130_assertion SIO_000772 19760522 NP181661.RAyju-kl1KkTd36Ulc9OLK2isBjWfu7Mv9zR_cQw2Vv8k130_provenance.
- NP181661.RAyju-kl1KkTd36Ulc9OLK2isBjWfu7Mv9zR_cQw2Vv8k130_assertion wasDerivedFrom befree-20140225 NP181661.RAyju-kl1KkTd36Ulc9OLK2isBjWfu7Mv9zR_cQw2Vv8k130_provenance.
- NP181661.RAyju-kl1KkTd36Ulc9OLK2isBjWfu7Mv9zR_cQw2Vv8k130_assertion wasGeneratedBy ECO_0000203 NP181661.RAyju-kl1KkTd36Ulc9OLK2isBjWfu7Mv9zR_cQw2Vv8k130_provenance.
- befree-20140225 importedOn "2014-02-25" NP181661.RAyju-kl1KkTd36Ulc9OLK2isBjWfu7Mv9zR_cQw2Vv8k130_provenance.